Market - Page 7 of 327 - Express Pharma

Cadila Pharmaceuticals launches Empadon (Empagliflozin)

Quadria Capital closes oversubscribed $1 bn fund III to advance healthcare across Asia

Biocon Biologics, Yoshindo launch Ustekinumab biosimilar in Japan

Cipla launches ZEMDRI (Plazomicin) in India, aims to tackle AMR

Barentz acquires Fengli, China, aims to strengthen market presence

Tezepelumab’s trial results strengthen potential for biomarker-driven biologic therapies in COPD: GlobalData

US drug pricing order – Implications for India’s pharma sector

Gene therapies drive growth of genomics market, says GlobalData

Accretion Pharmaceuticals’ IPO opens for subscription, price band set at ₹96-101 per share

ATMF report reveals that insulin remains out of reach for T1D patients in LMICs, children facing gross inequities